Arthrosin TS750 mg+600 mg

Arthrosin TS is a dietary/nutraceutical combination used mainly for symptomatic relief of osteoarthritis (OA), most commonly of the knee, hip, spine, and hand joints.

• Osteoarthritis symptom relief (primary use): Used as a complementary/supportive measure to help reduce joint pain and stiffness and improve function in mild-to-moderate OA. Clinical trial evidence for efficacy is mixed and generally modest; some patients experience meaningful symptom improvement while others show little benefit compared with placebo.
• Adjunct therapy: Commonly used alongside standard, physician-directed OA management (analgesics/NSAIDs as prescribed, weight control, physiotherapy, exercise) rather than as a replacement for these measures.
• Other proposed uses (limited/off-label evidence): Has been tried for joint symptoms associated with rheumatoid arthritis and sports-related joint injuries; evidence for these uses is limited and not well established.

Arthrosin TS should not be considered a substitute for disease-modifying treatment or physician-directed management of arthritis.

Each tablet/capsule of Glucosamine Sulfate + Chondroitin typically contains Glucosamine Sulfate (usually as the potassium chloride or sodium chloride complex) 250 mg or 750 mg combined with Chondroitin Sulfate 200 mg or 600 mg respectively. Strengths and combination ratios vary by manufacturer; common regimens supply approximately 1000-1500 mg glucosamine sulfate and 800-1200 mg chondroitin sulfate per day in divided doses.

Arthrosin TS is a combination nutraceutical/dietary supplement composed of two naturally occurring substances found in and around joint cartilage. Glucosamine is an amino sugar involved in the synthesis of glycosaminoglycans and proteoglycans, key structural components of cartilage, while Chondroitin Sulfate is a glycosaminoglycan that helps maintain cartilage elasticity and resist compressive forces. Together, Arthrosin TS is marketed to support joint health and to help relieve the pain and stiffness of osteoarthritis, most often affecting the knee. It is classified as a Symptomatic Slow-Acting Drug/agent for Osteoarthritis (SYSADOA) rather than a conventional pharmaceutical, and clinical evidence for its benefit is modest and inconsistent across studies.

Nutraceutical/Dietary Supplement - Cartilage-protective agent; Symptomatic Slow-Acting Drug for Osteoarthritis (SYSADOA)

Glucosamine Sulfate + Chondroitin combines two cartilage-matrix constituents thought to act through complementary mechanisms:

• Glucosamine Sulfate: An amino-monosaccharide precursor used by chondrocytes to synthesize glycosaminoglycans, proteoglycans, and hyaluronic acid, which are essential building blocks of articular cartilage. It may also have mild anti-inflammatory effects by reducing production of certain inflammatory mediators and cartilage-degrading enzymes in vitro.
• Chondroitin Sulfate: A sulfated glycosaminoglycan that contributes to the elasticity and shock-absorbing properties of cartilage. It is proposed to inhibit degradative enzymes (such as matrix metalloproteinases and elastase) and to stimulate proteoglycan and collagen synthesis by chondrocytes.

Absorption after oral administration is variable; the components are absorbed from the gastrointestinal tract, distributed to joint tissues, and eliminated mainly via the kidneys. The overall clinical effect of Glucosamine Sulfate + Chondroitin on cartilage structure and long-term disease progression remains unproven, and any symptomatic benefit typically takes several weeks to become apparent.

Take Arthrosin TS by mouth with food or meals to minimize stomach upset. Swallow tablets/capsules whole with a glass of water; do not crush or chew unless the specific product is formulated as chewable. Take doses at evenly spaced intervals as directed on the product label or by a physician.

Arthrosin TS has the following clinically notable interaction:

• Warfarin and other oral anticoagulants: Concurrent use may potentiate the anticoagulant effect and increase INR, raising the risk of bleeding. Patients on warfarin or similar anticoagulants who wish to take Arthrosin TS should inform their physician so that INR can be monitored more closely, especially when starting or stopping the supplement.

Theoretical interactions with anti-diabetic medications (via possible effects on insulin sensitivity) and with antiplatelet agents have been suggested but are not well established; caution and physician advice are reasonable in these situations. Always inform your doctor or pharmacist about all medicines and supplements being taken before starting Arthrosin TS.

Arthrosin TS is generally well tolerated, with a side-effect profile close to placebo in clinical trials. When they occur, side effects are usually mild and reversible and may include:

• Gastrointestinal: nausea, dyspepsia, abdominal pain, flatulence, diarrhea, or constipation
• Headache and drowsiness
• Skin reactions such as mild rash or itching (uncommon)

Rarely, worsening of asthma symptoms has been reported (see Precautions and Warnings). Patients who develop signs of an allergic reaction (rash, swelling, difficulty breathing) while taking Arthrosin TS should stop the product and seek medical attention.

Data on the safety of Arthrosin TS in human pregnancy and lactation are insufficient. As a general precaution, Arthrosin TS should be avoided during pregnancy and breastfeeding unless a physician determines that the potential benefit clearly justifies the potential risk, given the lack of robust safety data. Pregnant or breastfeeding women should consult a physician before using Arthrosin TS.

Use Arthrosin TS with caution in the following situations:

• Diabetes mellitus: Glucosamine may theoretically affect insulin sensitivity and blood glucose control; diabetic patients should monitor blood glucose more closely while using Arthrosin TS and inform their physician.
• Asthma: Rare reports of asthma exacerbation have been associated with glucosamine-containing products; patients with asthma should use Arthrosin TS cautiously and seek medical advice if symptoms worsen.
• Anticoagulant therapy (e.g., warfarin): May potentiate anticoagulant effect (see Interactions); requires closer INR monitoring.
• Shellfish allergy: See Contraindications.
• Hepatic or renal impairment: Use with caution in patients with significant liver or kidney disease, as safety data in these populations are limited.

Arthrosin TS is a supportive/complementary therapy; evidence for its efficacy in osteoarthritis is modest and inconsistent, and it should not replace standard, physician-directed management of arthritis or delay appropriate medical care.

Reports of serious toxicity from overdose of Arthrosin TS are limited, but taking substantially more than the recommended dose may increase the likelihood of gastrointestinal side effects (nausea, vomiting, diarrhea, abdominal discomfort). If an overdose is suspected, stop the product and seek immediate medical attention or contact a poison control center/emergency services; do not attempt to manage a suspected overdose at home without medical guidance.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

Children: Arthrosin TS is not recommended for use in children, as safety and efficacy have not been established in this age group.

Elderly: No specific dose adjustment is generally required in older adults, but this population is more likely to have comorbidities (e.g., diabetes, renal impairment, concurrent anticoagulant use) requiring the precautions noted above; use under physician guidance.

Renal/Hepatic impairment: Use with caution in patients with significant renal or hepatic insufficiency; consult a physician (see Precautions and Warnings).

A trial of at least 2-3 months is generally needed before deciding whether Arthrosin TS is providing symptomatic benefit; some clinical studies have used continuous treatment for up to 6 months to 2 years. Ongoing use should be reviewed periodically with a physician, and the product should be discontinued if no meaningful benefit is noticed after an adequate trial.

Nutraceutical/Dietary Supplement; Cartilage-protective agent (SYSADOA - Symptomatic Slow-Acting Drug for Osteoarthritis)

Glucosamine Sulfate supplies a key building block (amino sugar) for synthesis of glycosaminoglycans and proteoglycans in cartilage, while Chondroitin Sulfate helps maintain cartilage elasticity and inhibits enzymes that degrade cartilage matrix; together, as Glucosamine Sulfate + Chondroitin, they are proposed to support cartilage structure and reduce inflammatory mediators involved in osteoarthritis, though the clinical significance of these effects is not firmly established.

Safety and efficacy of Arthrosin TS have not been established in children, and its use in this age group is not recommended.